Insmed
INSM
INSM
213 hedge funds and large institutions have $2.54B invested in Insmed in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 79 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 223 → 213 (-10)
12% less capital invested
Capital invested by funds: $2.89B → $2.54B (-$355M)
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
Holders
213
Holding in Top 10
4
Calls
$2.54M
Puts
$2.2M
Top Buyers
| 1 | +$15M | |
| 2 | +$13.8M | |
| 3 | +$12.9M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$12.7M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$12.3M |
Top Sellers
| 1 | -$31.8M | |
| 2 | -$15.3M | |
| 3 | -$13.9M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$13.4M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$12.3M |